Answers are grounded in this paper and cite their sources.
Overall, CCL2 is implicated in the pathways recruiting microglia and the development of pTau pathology after exposure to RHI, and may represent a future therapeutic target in CTE.
No takes yet. Share an insight, caveat, or question.
Cherry et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: